---
title: Neurological outcome in long-chain hydroxy fatty acid oxidation disorders
date: '2024-01-24'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38263760/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240124170612&v=2.18.0
source: heidelberg[Affiliation]
description: 'OBJECTIVE: This study aims to elucidate the long-term benefit of newborn
  screening (NBS) for individuals with long-chain 3-hydroxy-acyl-CoA dehydrogenase
  (LCHAD) and mitochondrial trifunctional protein (MTP) deficiency, inherited metabolic
  diseases included in NBS programs ...'
disable_comments: true
---
OBJECTIVE: This study aims to elucidate the long-term benefit of newborn screening (NBS) for individuals with long-chain 3-hydroxy-acyl-CoA dehydrogenase (LCHAD) and mitochondrial trifunctional protein (MTP) deficiency, inherited metabolic diseases included in NBS programs ...